Pacific Edge Says Total Laboratory Throughput Falls Over 13% Quarter-Over-Quarter In Fiscal 2026 Q3

MT Newswires Live

Jan 20

Pacific Edge (ASX:PEB, NZE:PEB) said total laboratory throughput in during the the three months to the end of December 2025 fell 13.4% to 5,446 tests from 6,286 in the previous quarter and the total laboratory throughput in US declined 19.5% to 4,003 tests from 4,971 in the second quarter of fiscal 2026, according to separate filings with the Australian and New Zealand bourses on Tuesday.

The number of ordering clinicians fell to 691 from 803 in the prior quarter. Asia-Pacific total laboratory throughput rose 9.7% quarter-over-quarter to 1,443 tests from 1,315.

Its Chief Executive, Peter Meintjes, said the throughput challenges were amplified by the seasonal holiday slowdown.

The firm is also pursuing appeals for all eligible Cxbladder Triage tests that were denied Medicare reimbursement since the Cxbladder non-coverage determination took effect in April 2025. The Office of Medicare Hearings and Appeals (OMHA) notified the firm that the first reimbursement appeal has been scheduled for a hearing before an Administrative Law Judge on Feb. 24.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2604629551"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2604629551\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2604629551?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-20 15:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2604629551","market":"sh","top_or_hot":-1,"title":"Pacific Edge Says Total Laboratory Throughput Falls Over 13% Quarter-Over-Quarter In Fiscal 2026 Q3","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/PFGTF\">Pacific Edge</a> (ASX:PEB, NZE:PEB) said total laboratory throughput in during the the three months to the end of December 2025 fell 13.4% to 5,446 tests from 6,286 in the previous quarter and the total laboratory throughput in US declined 19.5% to 4,003 tests from 4,971 in the second quarter of fiscal 2026, according to separate filings with the Australian and New Zealand bourses on Tuesday.</p><p>The number of ordering clinicians fell to 691 from 803 in the prior quarter. Asia-Pacific total laboratory throughput rose 9.7% quarter-over-quarter to 1,443 tests from 1,315.</p><p>Its Chief Executive, Peter Meintjes, said the throughput challenges were amplified by the seasonal holiday slowdown.</p><p>The firm is also pursuing appeals for all eligible Cxbladder Triage tests that were denied Medicare reimbursement since the Cxbladder non-coverage determination took effect in April 2025. The Office of Medicare Hearings and Appeals (OMHA) notified the firm that the first reimbursement appeal has been scheduled for a hearing before an Administrative Law Judge on Feb. 24.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pacific Edge Says Total Laboratory Throughput Falls Over 13% Quarter-Over-Quarter In Fiscal 2026 Q3</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPacific Edge Says Total Laboratory Throughput Falls Over 13% Quarter-Over-Quarter In Fiscal 2026 Q3\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-20 15:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/PFGTF\">Pacific Edge</a> (ASX:PEB, NZE:PEB) said total laboratory throughput in during the the three months to the end of December 2025 fell 13.4% to 5,446 tests from 6,286 in the previous quarter and the total laboratory throughput in US declined 19.5% to 4,003 tests from 4,971 in the second quarter of fiscal 2026, according to separate filings with the Australian and New Zealand bourses on Tuesday.</p><p>The number of ordering clinicians fell to 691 from 803 in the prior quarter. Asia-Pacific total laboratory throughput rose 9.7% quarter-over-quarter to 1,443 tests from 1,315.</p><p>Its Chief Executive, Peter Meintjes, said the throughput challenges were amplified by the seasonal holiday slowdown.</p><p>The firm is also pursuing appeals for all eligible Cxbladder Triage tests that were denied Medicare reimbursement since the Cxbladder non-coverage determination took effect in April 2025. The Office of Medicare Hearings and Appeals (OMHA) notified the firm that the first reimbursement appeal has been scheduled for a hearing before an Administrative Law Judge on Feb. 24.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PEB.AU","symbol_name":"PACIFIC EDGE LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2604629551","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2604629551","pubTimestamp":1768892890,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Pacific Edge  said total laboratory throughput in during the the three months to the end of December 2025 fell 13.4% to 5,446 tests from 6,286 in the previous quarter and the total laboratory throughput in US declined 19.5% to 4,003 tests from 4,971 in the second quarter of fiscal 2026, according to separate filings with the Australian and New Zealand bourses on Tuesday.The number of ordering clinicians fell to 691 from 803 in the prior quarter. Asia-Pacific total laboratory throughput rose 9.7% quarter-over-quarter to 1,443 tests from 1,315.Its Chief Executive, Peter Meintjes, said the throughput challenges were amplified by the seasonal holiday slowdown.The firm is also pursuing appeals for all eligible Cxbladder Triage tests that were denied Medicare reimbursement since the Cxbladder non-coverage determination took effect in April 2025. The Office of Medicare Hearings and Appeals  notified the firm that the first reimbursement appeal has been scheduled for a hearing before an Admini","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PEB.AU":"PACIFIC EDGE LTD","PEB.NZ":"Pacific Edge Limited Ordinary Shares","BK7067":"生物科技","TSS":"Total System Services","BK8033":"生物科技"},"translate_title":"Pacific Edge表示2026财年第三季度实验室总吞吐量环比下降13%以上","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PEB.AU":1,"TSS":1.5,"PEB.NZ":1.5},"content_text":"Pacific Edge (ASX:PEB, NZE:PEB) said total laboratory throughput in during the the three months to the end of December 2025 fell 13.4% to 5,446 tests from 6,286 in the previous quarter and the total laboratory throughput in US declined 19.5% to 4,003 tests from 4,971 in the second quarter of fiscal 2026, according to separate filings with the Australian and New Zealand bourses on Tuesday.The number of ordering clinicians fell to 691 from 803 in the prior quarter. Asia-Pacific total laboratory throughput rose 9.7% quarter-over-quarter to 1,443 tests from 1,315.Its Chief Executive, Peter Meintjes, said the throughput challenges were amplified by the seasonal holiday slowdown.The firm is also pursuing appeals for all eligible Cxbladder Triage tests that were denied Medicare reimbursement since the Cxbladder non-coverage determination took effect in April 2025. The Office of Medicare Hearings and Appeals (OMHA) notified the firm that the first reimbursement appeal has been scheduled for a hearing before an Administrative Law Judge on Feb. 24.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}